Literature DB >> 26408552

Synergy between acid and endotoxin in an experimental model of aspiration-related lung injury progression.

Konstantin Tetenev1, Mary E Cloutier2, Jessica A von Reyn2, Jennifer L Ather2, James Candon2, Gilman B Allen3.   

Abstract

Aspiration is a common cause of lung injury, but it is unclear why some cases are self-limited while others progress to acute respiratory distress syndrome (ARDS). Sporadic exposure to more than one insult could account for this variable progression. We investigated whether synergy between airway acid and endotoxin (LPS) amplifies injury severity in mice and whether LPS levels in human patients could corroborate our experimental findings. C57BL/6 mice aspirated acid (pH 1.3) or normal saline (NS), followed by LPS aerosol or nothing. Bronchoalveolar lavage fluid (BALF) was obtained 2 to 49 h later. Mice were injected with FITC-dextran 25 h after aspiration and connected to a ventilator, and lung elastance (H) measured periodically following deep inflation (DI). Endotracheal and gastric aspirates were also collected from patients in the intensive care unit and assayed for pH and LPS. Lung instability (ΔH following DI) and pressure-volume hysteresis in acid- or LPS-exposed mice was greater than in controls but markedly greater in the combined acid/LPS group. BALF neutrophils, cytokines, protein, and FITC-dextran in the acid/LPS mice were geometrically higher than all other groups. BALF from acid-only mice markedly amplified LPS-induced TNF-α production in cultured macrophages. Human subjects had variable endotracheal LPS levels with the highest burden in those at higher risk of aspiration. Acid aspiration amplifies LPS signaling in mice to disrupt barrier function and lung mechanics in synergy. High variation in airway LPS and greater airway LPS burden in patients at higher risk of aspiration could help explain the sporadic progression of aspiration to ARDS.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  ARDS; acid aspiration; acute lung injury; endotoxin; forced oscillations; lung mechanics; respiratory impedance

Mesh:

Substances:

Year:  2015        PMID: 26408552      PMCID: PMC4652145          DOI: 10.1152/ajplung.00197.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  39 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

Review 2.  Aspiration pneumonitis and aspiration pneumonia.

Authors:  P E Marik
Journal:  N Engl J Med       Date:  2001-03-01       Impact factor: 91.245

3.  Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins.

Authors:  M A Dentener; A C Vreugdenhil; P H Hoet; J H Vernooy; F H Nieman; D Heumann; Y M Janssen; W A Buurman; E F Wouters
Journal:  Am J Respir Cell Mol Biol       Date:  2000-08       Impact factor: 6.914

4.  Acid instillation enhances the inflammatory response to subsequent lipopolysaccharide challenge in rats.

Authors:  H Yamada; H Miyazaki; T Kikuchi; J Fujimoto; I Kudoh
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

5.  TNF-alpha increases sensitivity to LPS in chronically catheterized rats.

Authors:  M Goto; L V Deriy; Y J Chen; D W Beno; M R Uhing; V A Jiyamapa-Serna; R E Kimura
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-06       Impact factor: 4.733

6.  Decreased surfactant protein-B expression and surfactant dysfunction in a murine model of acute lung injury.

Authors:  E P Ingenito; R Mora; M Cullivan; Y Marzan; K Haley; L Mark; L A Sonna
Journal:  Am J Respir Cell Mol Biol       Date:  2001-07       Impact factor: 6.914

7.  Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

8.  Immunopathology of a two-hit murine model of acid aspiration lung injury.

Authors:  J A Nemzek; D R Call; S J Ebong; D E Newcomb; G L Bolgos; D G Remick
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-03       Impact factor: 5.464

9.  Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome.

Authors:  T R Martin; G D Rubenfeld; J T Ruzinski; R B Goodman; K P Steinberg; D J Leturcq; A M Moriarty; G Raghu; R P Baughman; L D Hudson
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

10.  Low pH environmental stress inhibits LPS and LTA-stimulated proinflammatory cytokine production in rat alveolar macrophages.

Authors:  Stanley F Fernandez; Christopher Fung; Jadwiga D Helinski; Ravi Alluri; Bruce A Davidson; Paul R Knight
Journal:  Biomed Res Int       Date:  2013-10-30       Impact factor: 3.411

View more
  4 in total

Review 1.  Plasma membrane wounding and repair in pulmonary diseases.

Authors:  Xiaofei Cong; Rolf D Hubmayr; Changgong Li; Xiaoli Zhao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-06       Impact factor: 5.464

2.  The anesthetic agent sevoflurane attenuates pulmonary acute lung injury by modulating apoptotic pathways.

Authors:  L Wang; Y Ye; H B Su; J P Yang
Journal:  Braz J Med Biol Res       Date:  2017-02-20       Impact factor: 2.590

3.  Capturing the multifactorial nature of ARDS - "Two-hit" approach to model murine acute lung injury.

Authors:  Sandra Hoegl; Nana Burns; Martín Angulo; Daniel Francis; Christopher M Osborne; Tingting W Mills; Michael R Blackburn; Holger K Eltzschig; Christine U Vohwinkel
Journal:  Physiol Rep       Date:  2018-03

4.  Pepsin Triggers Neutrophil Migration Across Acid Damaged Lung Epithelium.

Authors:  Bryan P Hurley; Rebecca H Jugo; Ryan F Snow; Tina L Samuels; Lael M Yonker; Hongmei Mou; Nikki Johnston; Rachel Rosen
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.